JD Supra

SEC Issues No-Action Letter Clarifying Rule 506(c) Accredited Investor Verification

On March 12, 2025, the Securities and Exchange Commission (the “SEC”) Division of Corporate Finance issued a no-action letter (the “Letter”) 1 clarifying “reasonable steps” issuers can take to verify ...
JD Supra

SEC's Advocate for Small Business Capital Formation Explores the Use of Rule 506(c) Offerings by Alternative Investment Managers

A recent report from the SEC's Office of the Advocate for Small Business Capital Formation presents a study on how the Rule 506(c) exemption under Regulation D of the Securities Act of 1933 is used in ...
Crowdfund Insider

Accredited Investor: A Little Less Red Tape, A Lot More Capital: What the SEC Just Did for Reg D Rule 506(c)

The U.S. Securities and Exchange Commission (SEC) just made a game-changing move for capital raisers utilizing Rule 506(c) under Regulation D. On March 12, 2025; the SEC issued two new C&DIs as well ...
Crowdfund Insider

SEC Updates Data on Exempt Securities Including Reg D, Reg CF, Reg A

The Division of Economic and Risk Analysis (DERA) at the Securities and Exchange Commission (SEC) has provided an update regarding information on exempt securities offerings, including Reg D, Reg CF, ...
Law

SEC Eases Investor Verification, Boosts Private Capital Fundraising, Lawyers Say

SEC Eases Investor Verification, Boosts Private Capital Fundraising, Lawyers Say The guidance deals with Rule 506 (c) under Regulation D, which since 2012 has permitted public fundraising and ...
Business Insider

RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement

Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments ...